- May 7, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Synonyms :
Class :
may decrease the therapeutic effect of COVID-19 vaccine
in combination with ofatumumab, canakinumab increases the risk of adverse events.
interaction raises immunosuppressive effects and risk of infection
may increase the toxic effect
when both drugs are combined, there may be an increased metabolism of paclitaxel
when both the drugs are combined, the metabolism of carmustine increases
when both drugs are combined, there may be an increased risk of serious infections
both the drugs increase the effect of immunosuppression risk of infection increases on administering both the drugs simultaneously
when both drugs are combined, there may be an increased risk of serious infections